SEP 24, 2019 7:00 PM PDT

Promising Drug for Prostate Cancer

WRITTEN BY: Nouran Amin

Using high-throughput screening methods, cancer researchers from the UK have identified some promising drug candidates to test thousands of molecules. Specifically, they studied a protein called-methylacyl-CoA racemase (AMACR) as a potential target for therapeutics in prostate cancers. The experiments show that reducing the AMACR protein makes cancer cells less aggressive and allows their behavior to be like normal cells.

“The protein AMACR has been shown to be present in larger quantities in aggressive prostate cancer cells, and this research group have successfully developed a technique to find the protein and monitor its activity. Further to this, they have now found certain compounds that can target this protein's activity in the lab, and stop the cancer cells in their tracks,” says Simon Grieveson, Head of Research Funding at Prostate Cancer UK.

The study examined more than 20,000 drug-like molecules that inhibit the activity of AMACR using a method known as simple color-change technique. The technique allows for quick assessment of active compounds and identification of new types of drugs. Findings were published in the journal Bioorganic Chemistry.

Lead author Dr Matthew Lloyd said: "Although previously identified drugs are very effective in laboratory tests, in practice they are difficult to use in therapies because their properties do not allow easy distribution throughout the body. We started this study because we wanted to identify drugs which would be easier to use therapeutically. Although the particular compounds identified in this study did not kill prostate cancer cells very effectively, it is very promising that drug-like molecules were identified,” says lead author of the study, Dr. Matthew Lloyd rom the University of Bath.

Learn more about prostate cancer:

“The research is still in its infancy and is some way off from clinical investigation, however this is certainly promising and we look forward to seeing how this research progresses over the coming years,” says Grieveson.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 22, 2019
Genetics & Genomics
DEC 22, 2019
New Gene Therapy Uses Exosomes to Reverse Disease
Researchers at Ohio State University have developed a new gene therapy that makes use of exosomes, fluid sacs released in cells, to carry therapeutic tools...
DEC 27, 2019
Drug Discovery & Development
DEC 27, 2019
New Drug to Treat Migraines Approved by FDA
Over 1 in 10 people around the world- or 780 million people. Three times more common in women than in men, until now, most treatments have been preventativ...
JAN 13, 2020
Drug Discovery & Development
JAN 13, 2020
Vaccine Against Alzheimer's to Hit Clinical Trials
Currently Alzheimer’s disease is thought to affect around 50 million people around the world, with this figure doubling every year. Currently with no...
JAN 15, 2020
Cancer
JAN 15, 2020
Hope for patients with AML
Research published recently in the medical journal EMBO Molecular Medicine brings hope for leukemia patients with a report that a common and cheap drug may...
FEB 11, 2020
Cannabis Sciences
FEB 11, 2020
Traffic Light System Best Way to Label Cannabis Edibles
Cannabis products have become increasingly popular. Yet, as they are still relatively new to the market, research has found that most consumers don’t...
FEB 18, 2020
Microbiology
FEB 18, 2020
Newly Found Glycopeptide Antibiotics Kill Bacteria in a New Way
The overuse and misuse of antibiotics and the adaptability of microbes has created a problem that people must solve....
Loading Comments...